Journal of Comparative Effectiveness Research

Papers
(The median citation count of Journal of Comparative Effectiveness Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Efficacy classification of modern therapies in multiple sclerosis69
Early mobilization in enhanced recovery after surgery pathways: current evidence and recent advancements66
The prevalence, characteristics and treatment of hemorrhoidal disease: results of an international web-based survey51
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis46
Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance37
COVID-19 complications in males and females: recent developments33
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients32
Evidence-based public policy making for medicines across countries: findings and implications for the future30
How does risdiplam compare with other treatments for Types 1–3 spinal muscular atrophy: a systematic literature review and indirect treatment comparison22
Robot-assisted minimally invasive transforaminal lumbar interbody fusion versus open transforaminal lumbar interbody fusion: a retrospective matched-control analysis for clinical and quality-of-life o20
Patient-related barriers to some virtual healthcare services among cancer patients in the USA: a population-based study20
The use of nonrandomized evidence to estimate treatment effects in health technology assessment19
Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus19
The prevalence, disease characteristics and treatment of chronic venous disease: an international web-based survey18
Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-201918
Safety and effectiveness of intranasal esketamine for treatment-resistant depression: a real-world retrospective study17
Economic analysis of the use of video laryngoscopy versus direct laryngoscopy in the surgical setting16
Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease16
Robotic-assisted total hip arthroplasty: an economic analysis15
What works when: mapping patient and stakeholder engagement methods along the ten-step continuum framework15
Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA14
Vaginal laser therapy for gynecologic conditions: re-examining the controversy and where do we go from here14
Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study)14
Evaluating patients' satisfaction and preferences with a secondary prevention cardiovascular polypill: the Aurora Study14
Digital technologies in cancer care: a review from the clinician's perspective13
Cost–effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke13
Unmeasured confounding in nonrandomized studies: quantitative bias analysis in health technology assessment13
A prospective, randomized, controlled, crossover study comparing three multilayered foam dressings for the management of chronic wounds13
Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data inROS1+ NSCLC12
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer12
Propensity score matching versus coarsened exact matching in observational comparative effectiveness research12
Network meta-analysis of nivolumab plus ipilimumab in the second-line setting for advanced hepatocellular carcinoma12
Effectiveness of clinical Pilates and home exercises in sagittal cervical disorientation: randomized controlled study12
Effect of clinical Pilates training on balance and postural control in patients with Parkinson’s disease: a randomized controlled trial12
Indirect treatment comparison of idecabtagene vicleucel versus conventional care in triple-class exposed multiple myeloma11
An investigation to choose the proper therapy technique in the management of autism spectrum disorder11
Estimates of the value of life lost from COVID-19 in Ohio10
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis10
Patient and caregiver experiences at a specialized primary care center for autistic adults10
Impact of telehealth on health care resource utilization during the COVID-19 pandemic10
The effects of pregnancy on relapse rates, disability and peripartum outcomes in women with multiple sclerosis: a systematic review and meta-analysis10
Impact of socioeconomic status on presentation, treatment and outcomes of patients with pancreatic cancer10
The next generation of rare disease drug policy: ensuring both innovation and affordability10
Single-arm oncology trials and the nature of external controls arms9
Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy9
The cost–effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark9
The terminology conflict on efficacy and effectiveness in healthcare9
Missing data methods for intensive care unit SOFA scores in electronic health records studies: results from a Monte Carlo simulation9
Potential policy reforms to strengthen the accelerated approval pathway9
Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers9
A systematic review of discounting in national health economic evaluation guidelines: healthcare value implications9
Are eSports more than just sitting? A study comparing energy expenditure8
Comparison of intravenous versus topical tranexamic acid in primary total hip arthroplasty: a systematic review and meta-analysis of ten randomized trials8
Advantages of robotic arm-assisted total hip arthroplasty: a 90-day episode-of-care clinical utility and cost analysis8
Gender, socioeconomic status and emergency department visits among cancer survivors in the USA: a population-based study8
The triple win – implementation science benefits patients, healthcare systems and industry alike8
Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy8
Identifying patient decisions and related information needs during decision making related to total knee arthroplasty8
Assessing direct costs of treating metastatic triple-negative breast cancer in the USA8
The effects of Pilates on pain, functionality, quality of life, flexibility and endurance in lumbar disc herniation7
Protocol for Digital Real-world Evidence trial for Adults with insomnia treated via Mobile (DREAM): an open-label trial of a prescription digital therapeutic for treating patients with chronic insomni7
Real-world treatment, clinical outcomes and healthcare resource utilization among persons with hemophilia A by age7
Cornerstones of ‘fair’ drug coverage: appropriate cost sharing and utilization management policies for pharmaceuticals7
Healthcare utilization among children with early autism diagnoses, children with other developmental delays and a comparison group7
Effects of 12-week Pilates training program on cardiac autonomic modulation: a randomized controlled clinical trial7
Health technology assessment (HTA) in England, France and Germany: what do matched drug pairs tell us about recommendations by national HTA agencies?7
Efficacy of immunotherapy with PD-1 inhibitor in colorectal cancer: a meta-analysis7
Palbociclib versus abemaciclib in HR+/HER2- advanced breast cancer: an indirect comparison of patient-reported end points7
Continuous vital sign monitoring in patients after elective abdominal surgery: a retrospective study on clinical outcomes and costs6
Sex-based differences in the outcomes of patients with lung carcinoids6
Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancer6
Factors affecting treatment selection and overall survival for first-line EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer6
The impact of lower limb chronic venous disease on quality of life: patient and physician perspectives6
Indirect treatment comparison of olaparib and talazoparib in germline BRCA-mutated HER2-negative metastatic breast cancer6
Navigating adalimumab biosimilars: an expert opinion6
Estimating the risk of thrombotic events in people with congenital hemophilia A using US claims data6
Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in colorectal cancer: a meta-analysis6
A review of stakeholder recommendations for defining fit-for-purpose real-world evidence algorithms6
Structural hemodynamic valve deterioration durability of RESILIA-tissue versus contemporary aortic bioprostheses6
Six ways to foster community-engaged research during times of societal crises6
Use of ibuprofen for the closure of patent ductus arteriosus in preterm infants: a systematic review of meta-analyses6
An observational cohort study of pelvic floor photobiomodulation for treatment of chronic pelvic pain6
The cost–effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK setting6
Do implantable loop recorders impact the survival of patients with recurrent unexplained syncope?6
TELEmedicine as an intervention for sepsis in emergency departments: a multicenter, comparative effectiveness study (TELEvISED Study)6
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 86
Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case–control design6
Comparative effectiveness of larotrectinib versus entrectinib for the treatment of metastatic NTRK gene fusion cancers6
Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema5
Cost–effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain5
Cost-per-remitter with esketamine nasal spray versus standard of care for treatment-resistant depression5
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment5
Implementation of the Connect for Health pediatric weight management program: study protocol and baseline characteristics5
Willingness to pay for a hypothetical malaria vaccine in Brazil: a cross-sectional study and the implications5
Respiratory and nonrespiratory COVID-19 complications in patients with obesity: recent developments5
Cost–effectiveness analysis of empagliflozin compared with glimepiride in patients with Type 2 diabetes in China5
Comparative efficacy of dabrafenib + trametinib versus treatment options for metastatic melanoma in first-line settings5
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada5
Comparative effectiveness of trastuzumab emtansine versus lapatinib plus chemotherapy for HER2+ metastatic breast cancer5
Optimizing electronic capture of patient-reported outcome measures in oncology clinical trials: lessons learned from a qualitative study5
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 125
Safety and efficacy of GP40071 compared with originator insulin aspart (NovoRapid ® Penfill ® ) in Type 1 diabetes mellitus5
Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil: a cross-sectional study and the implications5
Using UK Biobank for sexual minority health research4
Prednisone and deflazacort in Duchenne muscular dystrophy: a patient perspective and plain language summary publication of the Cincinnati study4
Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis4
Semaglutide treatment for obesity in teenagers: a plain language summary of the STEP TEENS research study4
Social determinants of health affect unplanned readmissions following acute myocardial infarction4
Assessing potential cures: are there distinctive elements of value beyond health gain?4
Patterns of emergency department visits preceding colorectal cancer diagnosis: a population-based study4
Meta-analysis of visual pretreatment for the prevention of emergence delirium in children undergoing ophthalmic surgery4
Amniotic fluid karyotype analysis and prenatal diagnosis strategy of 3117 pregnant women with amniocentesis indication4
Influence of pharmaceutical services organization on the availability of essential medicines in a public health system4
Dacomitinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: a cost–effectiveness analysis4
The societal impact of early intensified treatment in patients with type 2 diabetes mellitus4
Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink4
Impact of clinical pathways on treatment patterns and outcomes for patients with non-small-cell lung cancer: real-world evidence from a community oncology practice4
Application of quantitative bias analysis for unmeasured confounding in cost–effectiveness modelling4
Is Medicaid expansion associated with increases in palliative treatments for metastatic cancer?4
The societal impact of a biologic treatment of ankylosing spondylitis: a case study based on secukinumab4
Efficacy and safety of GP40021 insulin lispro biphasic compared with Humalog Mix 25 in Type 2 diabetes mellitus patients4
Comparative effectiveness of weekly versus every-2-weeks cetuximab in metastatic colorectal cancer in a US-insured population4
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 94
Strategies to improve the availability of medicines in primary health care in Brazil: findings and implications4
Real-world healthcare resource utilization and costs of weekly versus every-2-week cetuximab in metastatic colorectal cancer4
Economics of implementing an early deterioration detection solution for general care patients at a US hospital4
SPECT/CT versus planar imaging to determine treatment strategy for non-small-cell lung cancer: a cost–effectiveness analysis4
Economic burden of lives lost due to COVID-19 in New York State4
Discharges against medical advice and 30-day healthcare costs: an analysis of commercially insured adults4
Comparative effectiveness of glasdegib versus venetoclax combined with low-dose cytarabine in acute myeloid leukemia4
Cost–effectiveness of empagliflozin versus weekly semaglutide as add-on therapy for Type 2 diabetes4
Comparative effectiveness research in COVID-19 using real-world data: methodological considerations4
Trends in pharmaceutical expenditure in the Taiwan National Health Insurance database at different hospital levels4
Reliability of quantitative ultrasound measurement of flexor digitorum superficialis and profundus muscles in stroke4
For what it's worth: the complex area of medicine value assessment3
Characteristics of patients with chronic kidney disease and Type 2 diabetes initiating finerenone in the USA: a multi-database, cross-sectional study3
Impact of COVID-19 on chronic pain structures: data from French national survey3
Learning from the past to advance tomorrow’s real-world evidence: what demonstration projects have to teach us3
Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-world study3
Cost–effectiveness of second-line nivolumab for platinum-treated advanced non-small-cell lung cancer3
Review and estimation of disutility for joint health states of severe and nonsevere hypoglycemic events in diabetes3
Impact of surgical complications on hospital costs and revenues: retrospective database study of Medicare claims3
Recommendations from Cochrane reviews for improving future trials on anesthesia and pain: a meta-research study3
Real-world impact of patient-reported outcome measurement on overall survival, healthcare use and treatment discontinuation in cancer patients3
The prognostic impact of renal function decline during hospitalization for myocardial infarction3
Healthcare utilization in clinically significant tricuspid regurgitation patients with and without heart failure3
Acute effects of resistance exercise with blood flow restriction on cardiovascular response: a meta-analysis3
Factors impacting self-management ability in patients with chronic diseases in the United Arab Emirates, 20193
Cost–utility analysis of single nucleotide polymorphism panel-based machine learning algorithm to predict risk of opioid use disorder3
The health-related quality of life of patients with a benign gynecological condition: a 2-year follow-up3
Comparison of the effects of progressive supervised and home program exercise therapy in mild–moderatehallux valgus3
Cost–effectiveness of pembrolizumab for second-line treatment of esophageal squamous cell carcinoma patients with a combined positive score of 10 or more3
Opicapone as an add-on to levodopa for reducing end-of-dose motor fluctuations in Parkinson’s disease: a systematic review and meta-analysis3
Increasing transparency in indirect treatment comparisons: is selecting effect modifiers the missing part of the puzzle? A review of methodological approaches and critical considerations3
Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature review3
True cost of surgical aortic valve replacement and implications for price setting and diagnosis-related groups: evidence from a tertiary hospital in Eastern China3
Variant analysis of SARS-CoV-2 strains with phylogenetic analysis and the Coronavirus Antiviral and Resistance Database3
Adoption of video laryngoscopy by a major academic anesthesia department3
Clinical manifestations and healthcare utilization before diagnosis of transthyretin amyloidosis3
The acute effects of action observation training on upper extremity functions, cognitive processes and reaction times: a randomized controlled trial3
MASTRO I: Meta-Analysis and Systematic Review of thrombectomy stent retriever outcomes: comparing functional, safety and recanalization outcomes between EmboTrap, Solitaire and Trevo in acute ischemic3
Acceptability and consumers' willingness to pay for comprehensive medication management services in Brazil3
Impact of clinical research coordinators on research output in orthopedic surgery3
Identifying the unmet needs of individuals with Type 2 diabetes: an international web-based survey3
Evaluation of patient/caregiver and healthcare provider knowledge, attitudes and behavior for safety and use of pexidartinib3
Breast-conserving surgery versus mastectomy for older women with triple-negative breast cancer: population-based study3
Bridging the gap between oncology clinical trials and real-world data: evidence on replicability of efficacy results using German claims data3
Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making3
Patient and stakeholder engagement learnings: PREP-IT as a case study3
Predicting optimal treatment regimens for patients with HR+/HER2- breast cancer using machine learning based on electronic health records3
US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior3
An economic and health outcome evaluation of telehealth in rural sepsis care: a comparative effectiveness study3
R WE ready for reimbursement? A round up of developments in RWE relating to health technology assessment: part 23
Economic burden of drug overdose deaths before and during the COVID-19 pandemic in the USA3
Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status3
Outcome domains and measures for pain in psoriasis used in registered trials: analysis of studies on ClinicalTrials.gov3
Diagnostic amyloid light chain amyloidosis hospitalizations associated with high acuity and cost: analysis of the Premier Healthcare Database3
Economic burden of complicated ureteral stent removal in patients with kidney stone disease in the USA3
Effects of two different stretching techniques on proprioception and hamstring flexibility: a pilot study3
Access to medicines in the Brazilian Unified Health System’s primary health care: assessment of a public policy3
Shifting demographics and comorbidity burden in adult Chinese urban patients with chronic hepatitis B, 2013 and 20163
Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome3
Adjusting for treatment crossover in the MAVORIC trial: survival in advanced mycosis fungoides and Sézary syndrome3
Cost–effectiveness of ensartinib for patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer in China3
A comparative cost analysis between two quick diagnosis units of different levels of complexity3
Teclistamab versus real-world physician’s choice of therapy in triple-class exposed relapsed/refractory multiple myeloma3
Economic burden of maternal mortality in the USA, 2018–20203
Why, whether and how to use high-flow nasal therapy in acute exacerbations of chronic obstructive pulmonary disease3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 103
Comparison of noninvasive prenatal screening for defined pathogenic microdeletion/microduplication syndromes and nonsyndromic copy number variations: a large multicenter study3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 113
Medication review with follow-up for cardiovascular outcomes: a trial based cost–utility analysis3
The effect of midodrine on lactate clearance in patients with septic shock: a pilot study3
Reasons and factors associated with inconclusiveness of systematic reviews about interventions for neuropathic pain3
Steroid switching in dystrophinopathy treatment: a US chart review of patient characteristics and clinical outcomes3
Cost-minimization analysis of teledermatology versus conventional care in the Brazilian National Health System2
Systematic literature review of evidence in amyloid light-chain amyloidosis2
Understanding characteristics of patients newly initiating ixekizumab: findings from the Corrona Psoriasis Registry2
The efficacy and safety of GP40081 (insulin aspart biphasic 30) compared with NovoMix ® 30 in Type 2 diabetes patients2
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 42
Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison2
Channeling effects in the prescription of new therapies: the case of emicizumab for hemophilia A2
Economic burden of rivaroxaban and warfarin among nonvalvular atrial fibrillation patients with obesity and polypharmacy2
Autograft versus allograft tenodesis for chronic ankle instability: a single-center retrospective comparative study2
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 142
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 72
Clinical outcomes of retrievable inferior vena cava filters for venous thromboembolic diseases2
End-of-life cost for lung cancer patients in Greece: a hospital-based retrospective study2
An economic evaluation of teledermatology care delivery for chronic skin diseases2
Impact analysis of expanding narrow-spectrum antibiotic use for children with ear, sinus and throat infections2
Engaging veterans in the research process: a practical guide2
Treatment patterns and economic burden of bacterial vaginosis among commercially insured women in the USA2
Protocol for the implementation of a statewide mobile addiction program2
Comparison of Enterprise stent 2 with 1 in assisting coiling of ruptured aneurysms: a real-world study2
Characteristics, completion and publication of PROSPERO records in regional anesthesia for acute perioperative pain2
Data limitations of administrative databases in examining healthcare disparities in anesthesiology2
Burden of tyrosine kinase inhibitor failure in Chinese chronic myeloid leukemia patients: a systematic literature review2
Impact of comparative effectiveness research on Medicare coverage of direct oral anticoagulants2
Economic burden of readmission due to postoperative cerebrospinal fluid leak in Chinese patients2
Indirect comparison of apomorphine sublingual film and levodopa inhalation powder for Parkinson's disease ‘OFF’ episodes2
DAPA-RWE: a retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain2
Usability evaluation of sufentanil sublingual tablet analgesia in patients following Enhanced Recovery After Surgery2
Real-world economic and clinical outcomes associated with current hemostatic matrix use in spinal surgery2
Access in all areas? A round up of developments in market access and health technology assessment: part 12
Clinical outcomes of powered and manual staplers in video-assisted thoracic surgery lobectomy for lung cancer2
Health technology assessments and real-world evidence: tell us what you want, what you really, really want2
Can cost–effectiveness principles be ignored in urgent times?2
Switch rates and total cost associated with apremilast and biologics in biologic-naive patients with psoriatic arthritis2
The real-world impact of National Institute for Health and Care Excellence's real-world evidence framework2
Real-world evidence of eteplirsen treatment effects in patients with Duchenne muscular dystrophy in the USA2
Effectiveness of tisagenlecleucel versus real-world standard of care in relapsed/refractory follicular lymphoma2
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France2
Implementation of electronic patient-reported outcomes for symptom monitoring during cancer treatment: the importance of getting it right2
A real-world comparison of the clinical and economic utility of OVA1 and CA125 in assessing ovarian tumor malignancy risk2
Cost–effectiveness of overactive bladder treatments from a US commercial and payer perspective2
Off-label antipsychotic use patterns among Texas Medicaid adults 2013–20162
Economic impact of multigene panel testing for hereditary breast and ovarian cancer2
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 62
Institute for Clinical and Economic Review – Peterson Health Technology Institute value assessment framework for digital health technologies2
Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration2
Antibacterial data synthesis challenges: a systematic review of treatments for complicated Gram-negative urinary tract infections2
Postoperative outcomes and anesthesia type in total knee arthroplasty in patients with obstructive sleep apnea2
0.044999122619629